Postapproval Outcomes: The Berlin Heart EXCOR Pediatric in North America

Keyphrases

• North America 100%
• Pediatric 100%
• Berlin Heart 100%
• Post-approval Changes 100%
• Investigational Device Exemption 100%
• Efficacy Groups 37%
• Dilated Cardiomyopathy 25%
• Myocarditis 25%
• United States 12%
• Adverse Events 12%
• Bleeding 12%
• Low Risk 12%
• Between-group 12%
• FDA-approved Drugs 12%
• Patient Safety 12%
• Safety Outcomes 12%
• Neurological Events 12%
• Diagnostic Categories 12%
• Population Rates 12%
• Exclusion Criteria 12%
• Event Rate 12%
• Diagnostic Information 12%
• Bridge to Transplantation 12%
• Bleeding Events 12%
• Successful Weaning 12%
• Real-life Cohort 12%
• Pediatric Ventricular Assist Device 12%
• On-device 12%
• Ideal Population 12%

Medicine and Dentistry

• Pediatrics 100%
• Ventricular Assist Device 100%
• Diagnosis 66%
• Dilated Cardiomyopathy 66%
• Myocarditis 66%
• Adverse Event 33%
• Transplantation 33%
• Bleeding 33%
• Apoplexy 33%
• Patient Safety 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Cardiomyopathy 100%
• Myocarditis 100%
• Adverse Event 50%
• Bleeding 50%
• Cerebrovascular Accident 50%